Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO - Reuters

Reuters | July 29, 2025, 7:56 a.m. | Original
Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO Reuters
Exclusive: Trump administration slashed federal funding for gun violence prevention - Reuters Utility Duke Energy to sell Tennessee natural gas business for $2.48 billion - Reuters